Proposed
Everything else on this site is a decision a regulator has made. These are the ones still being asked for: an application sitting on a register, a draft regulation out for comment, a proposed rule. They are collected because a change usually appears here a year or two before it appears anywhere else.
An application is not an authorisation, and a proposal is not a prohibition.Nothing here has legal effect, many applications are withdrawn or refused, and this site does not guess at outcomes. Each entry says what stage the register records and links to it, so the current position can be checked at the source.
Great Britain
Apeel Sciences has asked the FSA to extend the use of mono- and diglycerides of fatty acids (E 471) to more fruits and vegetables.
The FSA/FSS Register of Regulated Product Applications lists RP-1057 as in progress at the risk management phase. The register summarises it as an extension-of-use application for the already authorised food additive E 471, mono- and diglycerides of fatty acids, adding produce categories to the list of fruits and vegetables it may be used on. A safety assessment is linked from the entry. The register publishes no date of receipt and no date of stage change: the only date it carries is a last-updated value of 1 September 2026, which is the same for all 449 entries.
SweeGen has asked the FSA to modify the specifications of steviol glycosides (E 960).
The FSA/FSS Register of Regulated Product Applications lists RP-1245, from SweeGen, Inc., as in progress at the risk management phase. The register summarises it as an application for a modification of the specifications of an already authorised food additive, steviol glycosides (E 960). The safety assessment linked from the entry is titled as covering a modification of specifications of rebaudioside D, E 960c. The register publishes no date of receipt and no date of stage change: the only date it carries is a last-updated value of 1 September 2026, which is the same for all 449 entries.
Enzymatically produced steviol glycosides · Steviol Glycosides (E 960)
LANXESS has asked the FSA to approve Nagardo as a food additive.
The FSA/FSS Register of Regulated Product Applications lists RP-1457, from LANXESS Deutschland GmbH, as in progress at the risk assessment phase. The register's whole summary is 'Application for the approval of Nagardo as a food additive'; it gives no E number, no function and no food categories, and links no assessment. The substance has no page on this site. The register publishes no date of receipt and no date of stage change: the only date it carries is a last-updated value of 1 September 2026, which is the same for all 449 entries.
Sweegen has asked the FSA to add a specification for rebaudioside E to enzymatically produced steviol glycosides (E 960c).
The FSA/FSS Register of Regulated Product Applications lists RP-2120, from Sweegen, Inc., as in progress at the risk assessment phase, the first of the register's three phases. The register summarises it as an application for an additional specification on an already authorised food additive, enzymatically produced steviol glycosides E 960c. It is the highest-numbered food additive application on the register. The register publishes no date of receipt and no date of stage change: the only date it carries is a last-updated value of 1 September 2026, which is the same for all 449 entries.
Enzymatically produced steviol glycosides · Rebaudioside E (Enzymatically produced steviol glycosides E 960c)
Bio Natural Solutions has asked the FSA to modify the conditions of use of sodium alginate (E 401) as a surface treatment for fresh fruit.
The FSA/FSS Register of Regulated Product Applications lists RP-290 as in progress and at the risk management phase, the second of the register's three phases. The register summarises it as an application to modify the conditions of use of an already authorised food additive, sodium alginate (E 401), when used as a coating material for an edible surface treatment of fresh fruits. A safety assessment for RP 290 is linked from the entry. The register publishes no date of receipt and no date of stage change: the only date it carries is a last-updated value of 1 September 2026, which is the same for all 449 entries.
Eat Just has asked the FSA to extend the use of curcumin (E 100) to egg analogues.
The FSA/FSS Register of Regulated Product Applications lists RP-41, from Eat Just, Inc., as in progress at the risk assessment phase. The register summarises it as an application for the use of curcumin (E 100) to be extended to egg analogues, solid and liquid, which it describes as plant-based products imitating the uses and organoleptic characteristics of conventional egg products. No safety assessment, consultation or advice to ministers is published against the entry. The register publishes no date of receipt and no date of stage change: the only date it carries is a last-updated value of 1 September 2026, which is the same for all 449 entries.
Eat Just has asked the FSA to extend the use of nisin (E 234) to egg analogues.
The FSA/FSS Register of Regulated Product Applications lists RP-42, from Eat Just, Inc., as in progress at the risk assessment phase. The register summarises it as an application for the use of nisin (E 234) to be extended to egg analogues, solid and liquid. It is one of three applications the same company has made for that food category. The register publishes no date of receipt and no date of stage change: the only date it carries is a last-updated value of 1 September 2026, which is the same for all 449 entries.
Nisin preparation · Nisin - Egg Analogues (liquid and solid)
Fermentalg has asked the FSA to authorise a phycocyanin-rich extract of Galdieria sulphuraria as a blue colour.
The FSA/FSS Register of Regulated Product Applications lists RP-507 as in progress at the risk assessment phase. The register summarises it as an application for the authorisation of a phycocyanin-rich extract from Galdieria sulphuraria as a blue colouring agent in a range of foodstuffs. The register spells the product name 'Blue microalgea extract'. The register publishes no date of receipt and no date of stage change: the only date it carries is a last-updated value of 1 September 2026, which is the same for all 449 entries.
United States
FDA has proposed to require a GRAS notice before a substance purported to be GRAS is used in human or animal food.
FDA published a proposed rule on 11 August 2026 that would require the submission of generally recognised as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act. Under the present regulations a GRAS notice is voluntary. The comment period runs to 9 December 2026, in docket FDA-2025-N-3262. The proposal concerns the notification procedure rather than any named substance, so it carries no additive slugs.
Substances purported to be generally recognised as safe (GRAS)
The Gardenia Blue Interest Group has petitioned FDA to widen the permitted uses of gardenia (genipin) blue and tighten its arsenic specification.
FDA's list of food additive and colour additive petitions under review or held in abeyance records CAP 6C0343 as filed on 4 August 2026 and under review as at 19 August 2026. The petition asks FDA to amend 21 CFR 73.168 to expand the safe use of gardenia (genipin) blue in various foods at levels consistent with good manufacturing practice, and to lower the arsenic specification from 2 mg/kg to 1 mg/kg. FDA announced the filing at 91 FR 53545 on 19 August 2026, in docket FDA-2026-C-8831.
The International Association of Color Manufacturers has petitioned FDA to allow acetone as a solvent in making carrot oil.
FDA's list of petitions under review or held in abeyance records CAP 5C0339 as filed on 3 August 2026 and under review. The petition asks FDA to amend 21 CFR 73.300 to provide for the safe use of acetone as a solvent in the manufacture of carrot oil, and to add heavy metal limits and secondary names for carrot oil. FDA announced the filing at 91 FR 53546 on 19 August 2026, in docket FDA-2026-C-8883.
Acetone, Carrot oil · Acetone as a solvent in the manufacture of carrot oil
FDA has proposed to repeal the colour additive listing for Citrus Red No. 2 on the skins of mature oranges.
FDA published a proposed order on 23 July 2026 that would repeal the colour additive regulation allowing Citrus Red No. 2 for colouring the skins of mature oranges. The proposal states that, based on certification data, it appears the colour is no longer used for that purpose. The comment period closed on 24 August 2026. No final rule appears in docket FDA-2026-N-6304 as at 19 September 2026.
GNT USA has petitioned FDA to list safflower extract as a colour additive exempt from certification.
FDA's list of petitions under review or held in abeyance records CAP 5C0338 as filed on 20 July 2026 and under review. The petition asks FDA to amend the colour additive regulations in 21 CFR part 73 to provide for the safe use of safflower (Carthamus tinctorius L.) extract as a colour additive in various foods at levels consistent with good manufacturing practices. FDA announced the filing at 91 FR 53545 on 19 August 2026, in docket FDA-2026-C-8086. The substance has no page on this site.
The International Association of Color Manufacturers has petitioned FDA to remove three solvents from the colour additive regulations.
FDA's list of petitions under review or held in abeyance records CAP 5C0340 as filed on 20 March 2026 and under review. The petition asks FDA to amend 21 CFR 73.1, 73.30, 73.345 and 73.615 to no longer provide for the use of methylene chloride, trichloroethylene and ethylene dichloride in preparing certain colour additives, on the ground that those uses have been permanently abandoned. FDA announced the filing at 91 FR 16169 on 1 April 2026, in docket FDA-2026-C-3071; comments closed on 1 June 2026.
Ethylene dichloride, Methylene chloride, Trichloroethylene · Methylene chloride, trichloroethylene and ethylene dichloride as solvents for colour additives
Ecoflora Cares has petitioned FDA to allow jagua (genipin-glycine) blue in pet foods.
FDA's list of petitions under review or held in abeyance records CAP 6C0341 as filed on 24 February 2026 and held in abeyance. FDA describes abeyance as an administrative category for petitions that are filed but non-active because of deficiencies identified during review. The petition asks FDA to amend 21 CFR 73.225 to provide for the safe use of jagua (genipin-glycine) blue as a colour additive in pet foods at levels consistent with good manufacturing practice. FDA announced the filing at 91 FR 10524 on 4 March 2026, in docket FDA-2026-C-2014.
Impossible Foods has petitioned FDA to expand the colour additive listing for soy leghemoglobin to plant-based meat, poultry and fish analogues.
FDA's list of petitions under review or held in abeyance records CAP 5C0336 as filed on 7 March 2025 and under review. The petition asks FDA to amend 21 CFR 73.520 to expand the safe use of soy leghemoglobin to include plant-based meat, poultry and fish analogue products. FDA announced the filing at 90 FR 12118 on 14 March 2025, in docket FDA-2025-C-0380.
Monterey Mushrooms has petitioned FDA to add a further manufacturing method for vitamin D2 mushroom powder.
FDA's list of petitions under review or held in abeyance records FAP 5A4841 as filed on 11 December 2024 and under review. The petition asks FDA to amend 21 CFR 172.382 to add vitamin D2 mushroom powder manufactured by exposing sliced or diced edible cultivars of Agaricus bisporus to ultraviolet light. FDA announced the filing at 89 FR 104908 on 26 December 2024, in docket FDA-2024-F-5640.
Phytolon has petitioned FDA to list prickly pear yellow as a colour additive exempt from certification.
FDA's list of petitions under review or held in abeyance records CAP 4C0332 as filed on 3 July 2024 and held in abeyance. The petition asks FDA to amend 21 CFR part 73 to provide for the safe use of prickly pear yellow for the colouring of foods generally, in amounts consistent with current good manufacturing practice. FDA announced the filing at 89 FR 58304 on 18 July 2024, in docket FDA-2024-C-3229. The substance has no page on this site.
Lonza Greenwood has petitioned FDA to allow sodium copper chlorophyllin in dietary supplement capsules and to add fescue grass as a source.
FDA's list of petitions under review or held in abeyance records CAP 4C0330 as filed on 26 March 2024 and held in abeyance. The petition asks FDA to amend 21 CFR 73.125 to provide for the safe use of sodium copper chlorophyllin in dietary supplement capsules at 0.08 to 0.4 percent of the weight of the capsule, and to add fescue grass (Festuca arundinacea) as a permitted source of the colour additive. FDA announced the filing at 89 FR 43349 on 17 May 2024, in docket FDA-2024-C-2295.
Environmental Defense Fund and others have petitioned FDA to remove three solvents from the colour additive regulations.
FDA's list of petitions under review or held in abeyance records CAP 4C0327 as filed on 21 December 2023 and under review. The petition asks FDA to amend 21 CFR 73.1, 73.30, 73.345 and 73.615 to remove ethylene dichloride, methylene chloride and trichloroethylene. FDA announced the filing at 89 FR 1856 on 11 January 2024 and reopened the comment period at 91 FR 31680 on 28 May 2026, closing 29 June 2026, in docket FDA-2023-C-5679. A separate petition on the same three solvents, CAP 5C0340, was filed by the International Association of Color Manufacturers in March 2026.
Ethylene dichloride, Methylene chloride, Trichloroethylene · Ethylene dichloride, methylene chloride and trichloroethylene as solvents for colour additives
Environmental Defense Fund and others have petitioned FDA to remove four solvents from the food additive regulations.
FDA's list of petitions under review or held in abeyance records FAP 4A4839 as filed on 21 December 2023 and under review. The petitioners are Environmental Defense Fund, Breast Cancer Prevention Partners, Center for Environmental Health, Environmental Working Group and Lisa Lefferts. The petition asks FDA to amend 21 CFR 172.560, 172.710, 173.230, 173.255, 173.290 and 173.315 to remove benzene, ethylene dichloride, methylene chloride and trichloroethylene. FDA announced the filing at 89 FR 1857 on 11 January 2024 and reopened the comment period at 91 FR 31681 on 28 May 2026, closing 29 June 2026, in docket FDA-2023-F-5684. Benzene has no page on this site.
Ethylene dichloride, Methylene chloride, Trichloroethylene · Benzene, ethylene dichloride, methylene chloride and trichloroethylene as solvents in food additive regulations
Kerry has petitioned FDA to allow sodium alginate as a stabiliser and thickener in plant protein products.
FDA's list of petitions under review or held in abeyance records FAP 3A4836 as filed on 9 August 2023 and held in abeyance. The petition asks FDA to amend 21 CFR part 172 to provide for the safe use of sodium alginate as a stabiliser and thickener in plant protein products at a level not to exceed 3 percent. FDA announced the filing at 88 FR 70919 on 13 October 2023, in docket FDA-2003-F-0321.
Kerry Ingredients and Flavours has petitioned FDA to allow vitamin D3 as a nutrient supplement in powdered drink mixes.
FDA's list of petitions under review or held in abeyance records FAP 2A4834 as filed on 26 April 2023 and under review. The petition asks FDA to amend 21 CFR 172.380 to provide for the safe use of vitamin D3 as a nutrient supplement in powdered drink mixes added to water or carbonated water, excluding drinks and drink mixes specially formulated or processed for infants. FDA announced the filing at 88 FR 70918 on 13 October 2023, in docket FDA-2023-F-4332.
Environmental Defense Fund and others have petitioned FDA to revoke the colour additive listing for titanium dioxide in food.
FDA's list of petitions under review or held in abeyance records CAP 3C0325 as filed on 14 April 2023 and under review. The petitioners are Environmental Defense Fund, Center for Environmental Health, Center for Food Safety, Center for Science in the Public Interest and Environmental Working Group, and the petition asks FDA to repeal 21 CFR 73.575, which provides for the use of titanium dioxide in food. FDA announced the filing at 88 FR 27818 on 3 May 2023 and extended the comment period at 88 FR 41870, closing 1 September 2023, in docket FDA-2023-C-1487. The European Union deleted titanium dioxide from its list of authorised food additives in 2022; the United States listing is unchanged.
Lallemand has petitioned FDA to allow vitamin D2 heat-killed baker's yeast as a source of vitamin D2 in specified foods.
FDA's list of petitions under review or held in abeyance records FAP 1A4829 as filed on 28 September 2021 and under review. The petition asks FDA to amend the food additive regulations in 21 CFR part 172 to provide for the safe use of vitamin D2 heat-killed ('inactive') baker's yeast as a source of vitamin D2 in specific food categories. FDA announced the filing at 86 FR 74018 on 29 December 2021, in docket FDA-2021-F-1157.
Vitamin D2 bakers yeast · Vitamin D2 heat-killed ("inactive") baker's yeast
A petition asks FDA to extend the permitted uses of synthetic iron oxide to edible decorative paint.
FDA's list of petitions under review or held in abeyance records CAP 1C0321 as filed on 28 June 2021 and held in abeyance. It was submitted by Australian Laboratory Services PTY LTD on behalf of Piotrovska PTY LTD, and asks FDA to amend 21 CFR 73.200 to expand the permitted uses of synthetic iron oxide as a colour additive to include use in edible decorative paint. FDA announced the filing at 86 FR 46803 on 20 August 2021, in docket FDA-2021-C-0787.
Monaghan Mushrooms has petitioned FDA to allow a vitamin D2 mushroom powder made by exposing dried powdered Agaricus bisporus to ultraviolet light.
FDA's list of petitions under review or held in abeyance records this petition as filed on 8 June 2021 and held in abeyance; the register displays it as FAP 1A4828 and addresses it by the identifier FAP_1A4848. It asks FDA to amend 21 CFR 172.382 to provide for the safe use of vitamin D2 mushroom powder produced by exposing dried and powdered edible cultivars of Agaricus bisporus to ultraviolet light. FDA announced the filing at 86 FR 50496 on 9 September 2021, in docket FDA-2021-F-0926. A second petition on the same regulation, FAP 5A4841 from Monterey Mushrooms, is under review.
Unilever has petitioned FDA to allow potassium iodate in salt added to selected food categories as a source of dietary iodine.
FDA's list of petitions under review or held in abeyance records FAP 0A4824 as filed on 25 November 2019 and held in abeyance. The petition asks FDA to amend the food additive regulations in 21 CFR part 172 to provide for the safe use of potassium iodate in salt added to select food categories as a source of dietary iodine. FDA announced the filing at 85 FR 10632 on 25 February 2020, in docket FDA-2020-F-0268.
A petition asks FDA to allow cassia gum in frozen dairy desserts, cheeses, and meat and poultry products.
FDA's list of petitions under review or held in abeyance records FAP 8A4772, from Lubrizol Advanced Materials, Inc., as filed on 7 April 2008 and held in abeyance. The register describes it as covering the use of cassia gum as a stabiliser in frozen dairy desserts and to improve texture and water retention in cheeses, meat and poultry products, under 21 CFR part 172. FDA announced the filing at 73 FR 29520 on 21 May 2008, in docket FDA-2008-F-0290.
FMC Health and Nutrition has petitioned FDA to allow sodium copper chlorophyllin in foods generally.
FDA's list of petitions under review or held in abeyance records CAP 6C0281 as filed on 9 November 2005 and held in abeyance. The petition asks FDA to amend 21 CFR 73.125 to provide for the safe use of sodium copper chlorophyllin in foods generally, with stated exceptions for meat, poultry, fish and standardised foods. FDA announced the filing at 70 FR 73252 on 9 December 2005, in docket 2005C-0482. A second, narrower petition on the same regulation, CAP 4C0330, was filed in 2024.
A 1990 petition asking FDA to prohibit the use of BHA is still recorded as under review.
FDA's list of petitions under review or held in abeyance records FAP 0A4216, from Glenn Scott, as filed on 22 June 1990 and under review. The register's whole description is 'Petition to prohibit the use of BHA', against 21 CFR 172.110, 172.515, 172.615, 173.340, 175.105 and 178.3570. FDA published a notice at 55 FR 49576 on 29 November 1990 and extended the comment period at 56 FR 3480 on 30 January 1991, in dockets 90F-0285 and 90P-0289.
The Calorie Control Council's petition on cyclamate has been held in abeyance by FDA since it was filed in 1982.
FDA's list of petitions under review or held in abeyance records FAP 2A3672, from the Calorie Control Council, as filed on 13 October 1982 and held in abeyance. The register gives its subject as cyclamate (cyclamic acid, calcium cyclamate and sodium cyclamate) and names no CFR section. FDA announced the filing at 47 FR 51227 on 12 November 1982, in docket 82F-0320. Cyclamate is not permitted in food in the United States; it is authorised in the European Union as E 952.
Cyclamate and its derivatives, Calcium cyclamate, Sodium cyclamate · Cyclamate (cyclamic acid, calcium cyclamate and sodium cyclamate)
A 1971 petition on the use of sodium nitrite in white fish is still recorded by FDA as held in abeyance.
FDA's list of petitions under review or held in abeyance records FAP 1A2671, from the U.S. Department of Commerce, as filed on 6 August 1971 and held in abeyance. The register gives its subject only as 'Sodium nitrite in white fish' and names no CFR section. The notice of filing appeared at 36 FR 10024 on 8 September 1971. It is the oldest entry on FDA's list.
Australia and New Zealand
FSANZ has accepted an application to permit honey truffle sweet protein as an intense sweetener.
FSANZ lists A1359 as a current application in its Additive category, published on 30 July 2026. The application seeks to permit the use of honey truffle sweet protein from Komagataella phaffii, with Mattirolomyces terfezioides as the gene donor, as an intense sweetening food additive. The only documents published against it are the administrative assessment report and an executive summary. The substance has no page on this site.
FSANZ has accepted an application to approve rebaudioside M and rebaudioside D made by enzymatic conversion using enzymes from Escherichia coli BL21.
FSANZ lists A1357 as a current application in its Additive category, published on 2 July 2026. The application seeks approval for the use of rebaudioside M and rebaudioside D, both steviol glycosides, produced by enzymatic conversion using enzymes derived from Escherichia coli BL21. The only documents published against it are the administrative assessment report and an executive summary.
Enzymatically produced steviol glycosides · Steviol glycosides (rebaudioside M and rebaudioside D) produced by enzymatic conversion using enzymes produced by Escherichia coli BL21
FSANZ has accepted an application to extend the use of steviol glycosides to hotplate flour products.
FSANZ lists A1325 as a current application in its Additive category, published on 4 March 2025, with the page last updated on 19 May 2026. The application seeks to extend the use of the food additive sweetener steviol glycosides to flour products produced on a hotplate: crumpets, pikelets and pancakes. It names no production route, so the slug here is the unqualified steviol glycosides listing. The only documents published against it are the administrative assessment report and an executive summary.
Steviol glycosides from Stevia rebaudiana Bertoni (Steviol glycosides from Stevia) · Steviol glycosides
European Union
The Commission has tabled a draft regulation that would add curdlan to Annex II to Regulation (EC) No 1333/2008 and to the specifications in Regulation (EU) No 231/2012.
The Comitology Register holds D114902 as a draft Commission Regulation before the Standing Committee on Plants, Animals, Food and Feed, section 'Novel Food and Toxicological safety of the food chain'. Version 1 was published on 16 April 2026 and version 2 on 3 July 2026, against the committee meeting of 13-14 April 2026, and the register carries the document comment 'PRAC 2 MOIS'. The register records a formal vote on 22 July 2026 with a favourable opinion, in voting sheet V117229. No corresponding regulation appears in EUR-Lex, and the consolidated text of Regulation (EC) No 1333/2008 as at 18 August 2026 does not mention curdlan.
The Commission has tabled a draft regulation that would amend the specifications for enzymatically produced steviol glycosides to include a rebaudioside M made with a genetically modified yeast.
The Comitology Register holds D114904 as a draft Commission Regulation before the Standing Committee on Plants, Animals, Food and Feed, section 'Novel Food and Toxicological safety of the food chain'. It would amend the Annex to Regulation (EU) No 231/2012 as regards the specifications for enzymatically produced steviol glycosides, to include rebaudioside M produced by enzymatic conversion of highly purified rebaudioside A from stevia leaf extract, E 960c(ii), using the genetically modified yeast Komagataella phaffii CGMCC 7539. Version 1 was published on 16 April 2026 and version 2 on 3 July 2026; the register records a favourable committee opinion on 22 July 2026 in voting sheet V117231. No corresponding regulation appears in EUR-Lex.
Enzymatically produced steviol glycosides · Enzymatically produced steviol glycosides (E 960c), rebaudioside M from enzymatic conversion of rebaudioside A using Komagataella phaffii CGMCC 7539
Where these come from
The dates mean different things. The FDA gives the date it filed a petition; the Commission's register gives the date a draft was published; Food Standards Australia New Zealand gives the date it published the application. The British register publishes no date for an application at all — its only date is when the register itself was last updated, and that is the same for every entry — so what is shown for Great Britain is that date, not the day the application was made. "Still open" means the register still lists it and no decision has been published as at that date; it is not a statement that a decision is coming.
Applications about food packaging and other food-contact materials are left out: this site covers substances added to food.
Great Britain publishes applications on the Food Standards Agency and Food Standards Scotland register; the European Commission publishes draft regulations in the comitology register and for public comment; the United States publishes proposed rules and petition filings in the Federal Register; Food Standards Australia New Zealand publishes the applications and proposals it has under assessment. Decisions, once made, move to Changes.